VivaVision Biotech Secures Over RMB 100 Million in Series D2 Financing for Ophthalmology Pipeline Expansion
China’s VivaVision Biotech Inc. has announced the successful completion of its Series D2 financing round,...
Finance
NeuExcell Therapeutics Secures Over $14.5 Million in Pre-Series A+ Funding for Neurological Treatments
NeuExcell Therapeutics, a Sino-US biotech company specializing in treatments for neurological damage and degenerative diseases,...
Q1 2023 financial report: AstraZeneca leads innovation in China, Sanofi’s sales in China decline
Several multinational companies (MNCs) have released their Q1 2023 financials, showing a varied performance over...
Reforgene Medicine Secures Pre-Series B Funding to Advance Thalassemia Gene Therapy
Reforgene Medicine, a Guangzhou-based gene editing therapy company, has reportedly secured hundreds of millions of...
Roche’s Q1 2023 Report: 3% Dip in Revenues with Strong Growth in Pharmaceuticals
Roche (SWX: ROG), the Swiss pharmaceutical and diagnostics giant, reported a 3% year-on-year (YOY) decrease...
Dizal Pharma Plans to Raise $376.1 Million for Drug R&D and Industrialization
Dizal (Jiangsu) Pharmaceutical Co., Ltd (SHA: 688192), the China-based joint venture established by AstraZeneca (AZ,...
Meilitech Secures Series A+ Funding Led by Autobio Diagnostics for Cancer Detection Tech
Shenzhen-based nanopore early cancer detection product developer, Meilitech Co., has reportedly raised tens of millions...
Beijing-Based Holox Secures Tens of Millions in Series A+ Financing for Healthcare Software
Holox, a Beijing-based developer of healthcare management software, has reportedly secured tens of millions of...
Shanghai Kingstar Winning Secures $43.39 Million in Series C Financing for Digital Healthcare Solutions
Shanghai Kingstar Winning Software Science and Technology Co., Ltd, a leading provider of digitalization risk...
CanSino Biotechnology Leads RMB 500 Million Private Equity Fund for Vaccine Investments
China-based vaccines specialist CanSino Biotechnology Inc., (HKG: 6185) has announced plans to invest RMB 140...
PharmaEssentia Corporation Completes Secondary Offering of GDR Shares on Luxembourg Exchange
Taiwan-based PharmaEssentia Corporation (TPE: 6446) has announced the successful closing of a secondary offering of...
Biosion Secures Series B+ Financing to Advance Antibody-Based Therapies Pipeline
Biosion, a global, clinical-stage biotech company dedicated to developing antibody-based therapies for immune and oncologic...
Hasten Biopharmaceutical Secures $315 Million Investment for Pipeline Expansion
China-based Hasten Biopharmaceutical Co., Ltd has reportedly received USD 315 million in a fundraising round...
Staidson Pharmaceutical Plans RMB 580 Million Private Placement for Drug R&D
China-based Staidson (Beijing) Pharmaceutical Co., Ltd (SHE: 300204) has announced plans to raise RMB 580...
Sangon Biotech Secures RMB 2 Billion in First Financing Round to Boost Life Science Services
China-based contract research organization (CRO) Sangon Biotech has secured RMB 2 billion (USD 290.3 million)...
Shenzhen 01 Life Science Secures RMB 100 Million in Series B1 Financing for Microecology Platform
Shenzhen 01 Life Science and Technology Ltd. Co., Ltd, a company specializing in human big...
Ubrigene Secures RMB 150 Million in Series C+ Financing to Expand Global CGT CDMO Platform
Yiming Cell Biotechnology Co., Ltd, known as Ubrigene Biosciences Inc., a leading gene and cell...
Shanghai Huikai Medical Technology Secures Series A+ Funding for Prostate Stent System
Shanghai Huikai Medical Technology Co., Ltd, a China-based urology device manufacturer, has reportedly raised tens...
Nanjing Chamlion Laser Technology Secures RMB 236 Million in Series B Financing for Dental 3D Printing
Nanjing Chamlion Laser Technology Co., Ltd, a leading provider of dental metal 3D printing solutions...
PackGene Secures Series C Financing to Boost AAV Innovation and Global Expansion
China-based PackGene Biotech has announced the successful completion of a Series C financing round, securing...